HIF1A siRNA was transfected into HepG2 cells under hypoxic conditions, downregulating HIF1A and its target gene VEGF at the mRNA and protein levels, with an antiangiogenic effect on liver cancer [179]. The gene discussed is HIF1A; the disease is liver cancer.